Modeling sequence - Sequence interactions for drug response

Min Lin, Hongying Li, Wei Hou, Julie A. Johnson, Rongling Wu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Motivation: Genetic interactions or epistasis may play an important role in the genetic etiology of drug response. With the availability of large-scale, high-density single nucleotide polymorphism markers, a great challenge is how to associate haplotype structures and complex drug response through its underlying pharmacodynamic mechanisms. Results: We have derived a general statistical model for detecting an interactive network of DNA sequence variants that encode pharmacodynamic processes based on the haplotype map constructed by single nucleotide polymorphisms. The model was validated by a pharmacogenetic study for two predominant beta-adrenergic receptor (βAR) subtypes expressed in the heart, β1AR and β2AR. Haplotypes from these two receptors trigger significant interaction effects on the response of heart rate to different dose levels of dobutamine. This model will have implications for pharmacogenetic and pharmacogenomic research and drug discovery.

Original languageEnglish (US)
Pages (from-to)1251-1257
Number of pages7
JournalBioinformatics
Volume23
Issue number10
DOIs
StatePublished - May 15 2007

Fingerprint

Haplotype
Drug Interactions
Pharmacodynamics
Haplotypes
Drugs
Single nucleotide Polymorphism
Pharmacogenetics
Nucleotides
Polymorphism
Single Nucleotide Polymorphism
Dobutamine
Interaction
Modeling
Adrenergic Receptors
Pharmaceutical Preparations
Epistasis
Drug Discovery
Interaction Effects
DNA sequences
Receptors, Adrenergic, beta

All Science Journal Classification (ASJC) codes

  • Statistics and Probability
  • Biochemistry
  • Molecular Biology
  • Computer Science Applications
  • Computational Theory and Mathematics
  • Computational Mathematics

Cite this

Lin, Min ; Li, Hongying ; Hou, Wei ; Johnson, Julie A. ; Wu, Rongling. / Modeling sequence - Sequence interactions for drug response. In: Bioinformatics. 2007 ; Vol. 23, No. 10. pp. 1251-1257.
@article{f38047860c134582b7a4565d3717d58c,
title = "Modeling sequence - Sequence interactions for drug response",
abstract = "Motivation: Genetic interactions or epistasis may play an important role in the genetic etiology of drug response. With the availability of large-scale, high-density single nucleotide polymorphism markers, a great challenge is how to associate haplotype structures and complex drug response through its underlying pharmacodynamic mechanisms. Results: We have derived a general statistical model for detecting an interactive network of DNA sequence variants that encode pharmacodynamic processes based on the haplotype map constructed by single nucleotide polymorphisms. The model was validated by a pharmacogenetic study for two predominant beta-adrenergic receptor (βAR) subtypes expressed in the heart, β1AR and β2AR. Haplotypes from these two receptors trigger significant interaction effects on the response of heart rate to different dose levels of dobutamine. This model will have implications for pharmacogenetic and pharmacogenomic research and drug discovery.",
author = "Min Lin and Hongying Li and Wei Hou and Johnson, {Julie A.} and Rongling Wu",
year = "2007",
month = "5",
day = "15",
doi = "10.1093/bioinformatics/btm110",
language = "English (US)",
volume = "23",
pages = "1251--1257",
journal = "Bioinformatics",
issn = "1367-4803",
publisher = "Oxford University Press",
number = "10",

}

Modeling sequence - Sequence interactions for drug response. / Lin, Min; Li, Hongying; Hou, Wei; Johnson, Julie A.; Wu, Rongling.

In: Bioinformatics, Vol. 23, No. 10, 15.05.2007, p. 1251-1257.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modeling sequence - Sequence interactions for drug response

AU - Lin, Min

AU - Li, Hongying

AU - Hou, Wei

AU - Johnson, Julie A.

AU - Wu, Rongling

PY - 2007/5/15

Y1 - 2007/5/15

N2 - Motivation: Genetic interactions or epistasis may play an important role in the genetic etiology of drug response. With the availability of large-scale, high-density single nucleotide polymorphism markers, a great challenge is how to associate haplotype structures and complex drug response through its underlying pharmacodynamic mechanisms. Results: We have derived a general statistical model for detecting an interactive network of DNA sequence variants that encode pharmacodynamic processes based on the haplotype map constructed by single nucleotide polymorphisms. The model was validated by a pharmacogenetic study for two predominant beta-adrenergic receptor (βAR) subtypes expressed in the heart, β1AR and β2AR. Haplotypes from these two receptors trigger significant interaction effects on the response of heart rate to different dose levels of dobutamine. This model will have implications for pharmacogenetic and pharmacogenomic research and drug discovery.

AB - Motivation: Genetic interactions or epistasis may play an important role in the genetic etiology of drug response. With the availability of large-scale, high-density single nucleotide polymorphism markers, a great challenge is how to associate haplotype structures and complex drug response through its underlying pharmacodynamic mechanisms. Results: We have derived a general statistical model for detecting an interactive network of DNA sequence variants that encode pharmacodynamic processes based on the haplotype map constructed by single nucleotide polymorphisms. The model was validated by a pharmacogenetic study for two predominant beta-adrenergic receptor (βAR) subtypes expressed in the heart, β1AR and β2AR. Haplotypes from these two receptors trigger significant interaction effects on the response of heart rate to different dose levels of dobutamine. This model will have implications for pharmacogenetic and pharmacogenomic research and drug discovery.

UR - http://www.scopus.com/inward/record.url?scp=34447319931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447319931&partnerID=8YFLogxK

U2 - 10.1093/bioinformatics/btm110

DO - 10.1093/bioinformatics/btm110

M3 - Article

C2 - 17392331

AN - SCOPUS:34447319931

VL - 23

SP - 1251

EP - 1257

JO - Bioinformatics

JF - Bioinformatics

SN - 1367-4803

IS - 10

ER -